Skip to main content
. Author manuscript; available in PMC: 2018 Jan 22.
Published in final edited form as: Emerg Med Clin North Am. 2014 Nov 15;33(1):179–196. doi: 10.1016/j.emc.2014.09.008

Table 5.

Some of the therapies recommended by the National Council for Radiation Protection and Measurements report number 161 and the Radiation Emergency Assistance Center and Training Site

Drug Indication
Alginates Internal contamination with radioactive strontium
British anti-Lewisite (BAL) Internal contamination with polonium
N-Acetylcysteine Internal contamination with radioactive cobalt

These therapies are not approved by the US Food and Drug Administration.